Acetamide derivatives and the use thereof as inhibitors of...

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 333/08 (2006.01) A61K 31/18 (2006.01) C07C 257/18 (2006.01) C07C 311/16 (2006.01) C07C 317/44 (2006.01) C07D 211/46 (2006.01) C07D 213/30 (2006.01) C07D 271/06 (2006.01) C07D 413/12 (2006.01)

Patent

CA 2417427

The invention relates to novel compounds of formula (I) wherein R, R1 and R2 have the designation cited in patent claim 1. Said compounds are inhibitors of the coagulation factors Xa and VIIa, and can be used to treat thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty, intermittent claudication, tumours, tumour diseases and/or tumour metastases.

Nouveaux composés de formule (I) dans laquelle R, R?1¿ et R?2¿ possèdent la signification figurant à la revendication 1, qui sont des inhibiteurs du facteur de coagulation Xa et VIIa et peuvent être utilisés pour traiter les thromboses, l'infarctus du myocarde, l'artériosclérose, les inflammations, l'apoplexie, l'angine de poitrine, la resténose après angioplastie, la claudication intermittente, les tumeurs, les maladies tumorales et / ou les métastases.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Acetamide derivatives and the use thereof as inhibitors of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Acetamide derivatives and the use thereof as inhibitors of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acetamide derivatives and the use thereof as inhibitors of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1894689

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.